Abstract

There is a paucity of data regarding pediatric liver transplant patients from Turkey and less so globally. We report here 7 pediatric cases with documented H1N1 nove Influenza A infection. 7 pediatric liver transplant patients on immunesuppression, tested positive with PCR for 2009 H1N1 Influenza A, have been analyzed retrospectively. All patients were commenced oseltamivir treatment and 6 patients continued to take their immunosuppressive treatment. All patients (n=7) survived H1N1 novel Influenza A infection without any sequela. 1 patient has been admitted to Intensive Care Unit and has been discharged without any sequela. There was no graft dysfunction or loss during the infection episode. 2009 H1N1 Influenza A infection did not cause any mortality among our patients. Oseltamivir treatment may have played a role for improving in our patients' condition. Immunosuppression can be continued in pediatric liver transplant patients with close monitoring of vital signs and graft function.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call